Home › Proteinuria › Florida
Proteinuria clinical trials in Florida
8 studies for Proteinuria are looking for participants at sites in Florida.
Cities in Florida
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Orlando
- Jade Clinical Site, Pembroke Pines
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Sep 25, 2026 · NCT07541287Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- Univ of Florida Shands Division, Gainesville
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 9, 2026 · NCT06994845A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #17, Boca Raton
- Investigator Site #6, Coral Springs
- Investigator Site #25, Hialeah
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 13, 2026 · NCT07268638Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Royal Research Corp, Hollywood
- Mayo Clinic Jacksonville, Jacksonville
- Florida Kidney Physicians, Riverview
- and 1 more
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 30, 2026 · NCT05268289Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
- Nicklaus Childrens Hospital, Miami
RecruitingPhase 3
Ages 12 to 60 · All sexes · Updated Jul 13, 2026 · NCT05755386Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
- Nicklaus Childrens Hospital, Miami
RecruitingPhase 3
Ages 12 to 60 · All sexes · Updated Jul 13, 2026 · NCT04817618Study of BHV-1400 in IgA Nephropathy
- Site-003, Miami Lakes
- Site-011, Miami Lakes
- Site-013, Orlando
- and 1 more
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684Proteinuria in Pre and Post Transplant
- University of Miami Miller School of Medicine Transplant Clinic, Miami
RecruitingObservational study
Up to age 25 · All sexes · Updated Nov 21, 2025 · NCT01094327From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.